- Home
- MITQ vs ENSC Comparison
MITQ vs ENSC Comparison
Compare MITQ & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITQ
- ENSC
- Stock Information
- Founded
- MITQ N/A
- ENSC 2003
- Country
- MITQ United States
- ENSC United States
- Employees
- MITQ N/A
- ENSC N/A
- Industry
- MITQ Telecommunications Equipment
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- MITQ Telecommunications
- ENSC Health Care
- Exchange
- MITQ Nasdaq
- ENSC Nasdaq
- Market Cap
- MITQ 8.0M
- ENSC 7.9M
- IPO Year
- MITQ 2021
- ENSC N/A
- Fundamental
- Price
- MITQ $0.73
- ENSC $6.14
- Analyst Decision
- MITQ
- ENSC
- Analyst Count
- MITQ 0
- ENSC 0
- Target Price
- MITQ N/A
- ENSC N/A
- AVG Volume (30 Days)
- MITQ 4.5M
- ENSC 62.8K
- Earning Date
- MITQ 02-12-2025
- ENSC 03-14-2025
- Dividend Yield
- MITQ N/A
- ENSC N/A
- EPS Growth
- MITQ N/A
- ENSC N/A
- EPS
- MITQ N/A
- ENSC N/A
- Revenue
- MITQ $18,756,000.00
- ENSC $4,421,404.00
- Revenue This Year
- MITQ N/A
- ENSC $89.78
- Revenue Next Year
- MITQ N/A
- ENSC N/A
- P/E Ratio
- MITQ N/A
- ENSC N/A
- Revenue Growth
- MITQ N/A
- ENSC 40.41
- 52 Week Low
- MITQ $0.42
- ENSC $2.12
- 52 Week High
- MITQ $1.55
- ENSC $18.45
- Technical
- Relative Strength Index (RSI)
- MITQ 50.27
- ENSC 40.62
- Support Level
- MITQ $0.68
- ENSC $5.55
- Resistance Level
- MITQ $0.76
- ENSC $7.36
- Average True Range (ATR)
- MITQ 0.07
- ENSC 0.67
- MACD
- MITQ -0.01
- ENSC -0.13
- Stochastic Oscillator
- MITQ 21.39
- ENSC 24.86
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.